Lista de obras - Yeşim Özgüler - Dominio Público Uruguay

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

artículo científico publicado en 2018

Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration

artículo científico publicado en 2018

Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence

artículo científico publicado en 2016

Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

artículo científico publicado en 2015

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

artículo científico publicado en 2017

Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-α treatment

artículo científico publicado en 2015

Inadequate reporting of enrolled patient and study site characteristics, and inter-study site differences in randomized controlled trials: A systematic review in six leading medicine journals

artículo científico publicado en 2016

Management of Behçet's syndrome

artículo científico publicado en 2014

Management of Behçet's syndrome

artículo científico publicado en 2015

Myelopathy in Behçet's disease: The Bagel Sign

artículo científico publicado en 2017

Peripheral blood mononuclear cell proteome profile in Behçet's syndrome

scientific article published on 14 August 2019

Pulmonary artery involvement in Behçet׳s syndrome: Effects of anti-Tnf treatment

artículo científico

Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy.

artículo científico publicado en 2016

Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al

scientific article published on 01 May 2016

Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.

artículo científico publicado en 2016

The OMERACT Core Set of Domains for Outcome Measures in Behçet Syndrome

scientific article published on 17 November 2020

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome

artículo científico publicado en 2021

Lista de obras de Yeşim Özgüler

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration

Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence

Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-α treatment

Inadequate reporting of enrolled patient and study site characteristics, and inter-study site differences in randomized controlled trials: A systematic review in six leading medicine journals

Management of Behçet's syndrome

Management of Behçet's syndrome

Myelopathy in Behçet's disease: The Bagel Sign

Peripheral blood mononuclear cell proteome profile in Behçet's syndrome

Pulmonary artery involvement in Behçet׳s syndrome: Effects of anti-Tnf treatment

Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy.

Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al

Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.

The OMERACT Core Set of Domains for Outcome Measures in Behçet Syndrome

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome